αPD-L1, CD40 agonist or the combination decreased tumor size and CD40 agonist increased spleen size in REX3 mice on day 14 posttumor (Supplementary Fig. 4A), similar to our prior study [28]. The gene discussed is CD40; the disease is neoplasm.